The global multiplex assays market size was valued at USD 3.2 billion in 2021 and is expected to reach USD 5.4 billion by 2028, at a CAGR of 7.6% during the forecast period 2022 to 2028. The Multiplex Assay is a method of profiling many analytes (such as proteins, biomolecules, growth regulators, cytokines, chemokines, and so on) by simultaneously detecting and measuring them. When compared to traditional approaches like ELISA, this test is used to amplify many targets during a polymerase chain reaction (PCR) and capture more information from minute quantities of proteins and other such analytes in less time. Pathogen identification, mutation analysis, RNA identification, gene detection analysis, linkage assessment, forensic research, and other applications are all common uses for multiplex assays. In addition to this, Multiplex Assays are employed in clinical trials because they reduce research costs and manual labour while maximizing the productivity of experiments and medicines. Additionally, they are automated and provide easier and faster disease analysis, fueling the growth of the Multiplex Assay Market.

View detailed report description here      

The advantages of multiplex assays over singleplex assays, the increased incidences of infectious diseases and cancer that can be identified easily at an earlier stage, government and private funding for research, and strategic acquisitions among market players to expand the reach of multiplex assay kits are all contributing to the market's growth. Furthermore, the market is expected to be constrained by the high cost of instruments used to perform multiplex assays, the shortage of diagnostic kits, and the scarcity of competent labour.

The global multiplex assays market segmentation:
1) By Product: Consumables, Instruments and Software Services.
2) By Type: Protein & Nucleic Acid Assay.
3) By Technology: Flow Cytometry, Fluorescence detection, Luminescence, Multiplex real-time PCR, Other technology.
4) By Application: Research & development, Drug discovery & development, Biomarker discovery & validation, Clinical diagnostic.
5) End User: Pharmaceutical and biotechnology companies, Hospitals, Research institutes, Clinical laboratories.

North America, followed by Europe, is expected to account for the largest share of this market. The increasing per capita healthcare expenditure and, as a result, the existence of technically sophisticated healthcare infrastructure in the North American market are driving growth. Different government associations' initiatives are also expected to promote market expansion in the next years.

Request sample report at                                                                                                              

Some of the major key players in the Multiplex Assays Market are Thermo Fisher Scientific Inc, Illumina Inc, Bio Rad Laboratories Inc, Qiagen, Abcam plc, BD

Precision Business Insights: 
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: | D U N S® Number: 852781747